Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Net Margin (2021 - 2025)

HeartSciences (HSCS) has disclosed Net Margin for 5 consecutive years, with 97269.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 9905698.0% year-over-year to 97269.0%, compared with a TTM value of 2545.7% through Oct 2025, down 362966.0%, and an annual FY2025 reading of 203517.79%, down 16771215.0% over the prior year.
  • Net Margin was 97269.0% for Q4 2025 at HeartSciences, up from 108305.63% in the prior quarter.
  • Across five years, Net Margin topped out at 9314.54% in Q3 2024 and bottomed at 108305.63% in Q3 2025.
  • Average Net Margin over 5 years is 33353.08%, with a median of 28006.39% recorded in 2023.
  • The sharpest move saw Net Margin soared 5764355bps in 2024, then plummeted -11762017bps in 2025.
  • Year by year, Net Margin stood at 10048.78% in 2021, then crashed by -389bps to 49178.25% in 2022, then grew by 9bps to 44830.28% in 2023, then skyrocketed by 104bps to 1787.98% in 2024, then tumbled by -5540bps to 97269.0% in 2025.
  • Business Quant data shows Net Margin for HSCS at 97269.0% in Q4 2025, 108305.63% in Q3 2025, and 1161.86% in Q2 2025.